top of page
About clinical studies
iPROLEPSIS will perform four different clinical studies:
1. iPROLEPSIS-PDPID
PsA digital phenotyping and inflammation drivers study.
2. iPROLEPSIS-MOJMI
Mast cells and optoacoustics-enabled joint and microvascular imaging study.
3. iPROLEPSIS-IDBV
Inflammation digital biomarkers validation study.
4. iPROLEPSIS-PPIDC
Prevention of PsA inflammation through digital care: an intervention study.
Clinical studies will be conducted in 5 countries:
Netherlands
UK
Portugal
Greece
Germany
Clinical studies
bottom of page